“Enriching Himself While Cutting Aid to Constituents”: BLOOMBERG Highlights Rob Bresnahan’s Growing Political Liabilities

Bloomberg reports that Bresnahan “already faces a $1 million ad campaign calling him out over Medicaid cuts, stinging hometown editorials, and sharp questions over selling stock in a Medicaid provider days before a critical vote for the measure.” And even Bresnahan concedes that he is facing disapproval from his own constituents, admitting to Bloomberg that “I also have a lot of people who may not be big fans” of his vote for the largest cuts to Medicaid in history.

Read key highlights from the new reporting below:

BLOOMBERG: Trump’s Tax Bill Faces A Big Test in This Pennsylvania District
By Jonathan Tamari | July 15, 2025

• In less than two weeks since President Donald Trump signed his new tax law, Rep. Rob Bresnahan (R-Pa.) already faces a $1 million ad campaign calling him out over Medicaid cuts, stinging home-town editorials, and sharp questions over selling stock in a Medicaid provider days before a critical vote for the measure.
• Amid the onslaught Vice President JD Vance is scheduled to visit Bresnahan’s working class district in northeastern Pennsylvania Wednesday to tout the law’s benefits, underscoring the importance of the swing district, and the fight to shape perceptions of the law.
• But with early polling finding Trump’s new law deeply unpopular, Democrats believe its cuts will help them win back some blue collar voters, who they say will bear the brunt of steep reductions in spending on Medicaid, the health program for people who are poor or disabled. 
• “We represent a swing district so there are a lot of mixed opinions,” Bresnahan said in an interview. “I have plenty of people who have reached out to thank me for supporting this bill, but I also have a lot of people who may not be big fans.”
• The GOP freshman won his seat by just 6,000 votes last year, and will attend Vance’s event Wednesday. The district includes some 200,000 people enrolled in Medicaid, close to 30% of the district, according to the nonpartisan health research group KFF. The bill includes around $1 trillion in cuts to Medicaid, and could cost nearly 12 million people their health coverage nationwide, nonpartisan analysts project.
• Bresnahan already faced a difficult re-election. Democrats argue that he’s now undercut his own supporters.
• “He knows how bad this bill’s going to be for his constituents, and when it came back to the House he voted for it anyway,” said Kobie Christian, a spokesperson for the liberal organization Unrig Our Economy.
• Many nonpartisan analysts, however, warn that even people eligible for Medicaid could lose coverage due to the new tangle of paperwork. And Democrats argue Bresnahan is particularly vulnerable because of his stock sales.
• On May 15, a week before the bill initially passed the House by a single vote, public disclosures show that Bresnahan sold between $1,000 and $15,000 of stock in Centene, a managed care organization that provides Medicaid coverage in more than two dozen states. The company’s stock fell as the measure advanced, including by roughly 40% after it cleared the Senate. The sale was one of more than 50 trades Bresnahan disclosed for May 15, and represents a small fraction of his portfolio.
• Democrats say it shows him enriching himself while cutting aid to constituents.
• “Bresnahan lied to voters when he repeatedly promised that he would protect Medicaid,” said Eli Cousin, a spokesperson for House Democrats’ national campaign arm. “We will use his own words, lies, and greed against him to ensure Northeastern Pennsylvanians know Bresnahan has violated the public trust and does not deserve to represent them.”